MAP4 and non-small cell lung carcinoma: Researchers found that the ratio of MAP4 to Stathmin mRNA in NSCLC tissues was higher than that in normal specimens, suggesting that this ratio may be a potential prognostic marker in NSCLC patients (Singharajkomron et al. 2022).